O2 Investment Partners ( ) announced today the appointment of Rob Hays as the firm’s Head of Investor Relations. Luke Plumpton announced the addition saying ...
Peer-reviewed publication validates the potential of Itay&Beyond's human CNS platform for advanced disease stratification, ...
Amani Therapeutics, a newly formed biotechnology company backed by RTW Investments, today announced the closing of a $25 million Series A financing. The company also announced the appointment of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results